Which compound categories should never be stacked with Trenbolone Enanthate due to additive progestogenic effects?

A second 19-nor androgen — specifically any form of Nandrolone — should not be combined with Trenbolone Enanthate. Both compounds activate the progesterone receptor, and their combined progestogenic load elevates prolactin to levels that a standard cabergoline protocol may struggle to control. Serum prolactin testing before and during any such stack is the minimum harm-reduction measure if the combination is attempted.

Why do 17-alpha-alkylated oral steroids represent an unfavorable addition to a Trenabol cycle?

Oral 17-alpha-alkylated compounds such as Oxymetholone introduce hepatic stress that overlaps with the lipid-panel suppression Trenbolone Enanthate already causes. Because both insults affect HDL and cardiovascular markers through partially shared pathways, the combined effect is non-additive in a dangerous direction — cardiovascular risk rises faster than either compound alone would predict. Liver enzyme panels and a full lipid profile should be checked before layering any oral on a Trenbolone Enanthate base.

What happens when high-dose aromatising testosterone is combined with Trenbolone Enanthate without proper ancillary management?

Running disproportionately high testosterone alongside Trenbolone Enanthate creates dual hormonal suppression of two separate axes — oestrogen and prolactin — simultaneously. A single aromatase inhibitor cannot address prolactin; cabergoline or bromocriptine handles prolactin, and an AI handles oestrogen. Managing both ancillary pathways effectively requires disciplined bloodwork, and the task becomes significantly harder when testosterone doses are high. Keeping testosterone in proportion to the Trenabol dose simplifies ancillary management considerably.

What is the advantage of Omega Meds Trenabol's 150mg/ml concentration compared to higher-concentration Trenbolone Enanthate products?

At 150 mg/ml, Trenabol is the lowest concentration in this product category, which gives users finer dose control per ampoule without drawing fractional volumes. Each 1 ml ampoule delivers exactly 150 mg — a figure that aligns with entry-level and harm-reduction dosing targets without requiring the sub-0.75ml draws that higher-concentration formulations demand. This makes precise weekly dose planning more straightforward for athletes who are simultaneously managing multiple ancillaries.

How does the single-dose ampoule format of Trenabol support safety when running a complex stack?

Each of Trenabol's ten ampoules is a sealed, single-use glass unit opened immediately before injection, which eliminates the repeated-needle-penetration contamination risk inherent to multi-use vials. When an athlete is already managing the increased monitoring burden of a multi-compound cycle, removing one potential sterility variable is a meaningful practical benefit. Unused ampoules remain factory-sealed until the moment of administration. (2) angle_used

Best Selling

Omega Meds

Trenabol 150mg/ml 10x1ml Ampullen by Omega Meds

Name: Trenabol 150mg/ml 10x1ml Ampoules by Omega Meds
Brand: Omega Meds
SKU: INJ-TENA-OME-150-016
Price: 56.00 EUR
Availability: InStock

Omega Meds Trenabol delivers Trenbolone Enanthate at 150 mg/ml across ten single-dose glass ampoules — a presentation engineered for athletes who require verified potency without the contamination variables of multi-use vials, and who need clear guidance on which co-administered compounds to avoid. At this concentration, every 1 ml ampoule provides a precise, pre-measured dose, making it straightforward to audit the stack against known contraindicated pairings. Batch-level quality assurance is applied through a dual analytical gate: HPLC potency confirmation establishes that the declared 150 mg/ml is accurate, and LAL endotoxin testing clears each production lot before distribution — both completed per batch, not per product line.

€56.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Precisely dosed at 150 mg per ampoule — the most granular Trenbolone Enanthate dose unit in this product group.
Single-dose sealed glass ampoules remove repeated-entry contamination risk during multi-compound administration protocols.
Non-aromatising androgen activity supports a lean muscular environment without requiring aggressive oestrogen management.
HPLC potency confirmation per batch means stated concentration is analytically verified, not assumed from formula.
LAL endotoxin testing at lot level clears each batch for injectable use before any ampoule leaves the facility.
Ten-ampoule presentation allows weekly dose adjustment without wastage across variable-length cycle structures.
Produced under GMP-compliant conditions, providing a documented quality baseline appropriate for a monitored stack.

Phase	Dosage	Note
Introductory / Stack Assessment	150 mg/week (1 ampoule)	Single ampoule per week allows baseline prolactin and lipid markers to be established before any second compound is introduced; avoid adding 19-nor agents during this phase.
Intermediate / Monitored Stack	300 mg/week (2 ampoules, split twice weekly)	If testosterone is co-administered, keep the testosterone dose proportionate; avoid layering oral 17-alpha-alkylated compounds on top of this dose.
Experienced / Pre-Contest	450 mg/week (3 ampoules, split twice or three times weekly)	At this dose level, dual ancillary management — aromatase inhibitor for oestrogen from co-administered testosterone, plus dopamine agonist for prolactin — becomes mandatory; no second 19-nor should be present in the stack.

Key takeaways

Avoid stacking Trenabol with any Nandrolone variant to prevent compounded prolactin elevation.
Exclude 17-alpha-alkylated orals from a Trenbolone Enanthate cycle to protect lipid and hepatic markers.
Monitor serum prolactin and HDL before adding any second compound to this stack.
Use Trenabol's 150 mg/ml concentration to maintain precise dose discipline across all stack phases.
Confirm each ampoule's HPLC batch data before adjusting weekly milligram targets based on bloodwork.

Trenabol 150 mg/ml: Trenbolone Enanthate With a Focus on What Not to Stack

Trenabol by Omega Meds is a single-active-ingredient injectable formulation of Trenbolone Enanthate at 150 mg/ml, supplied as ten individually sealed 1 ml ampoules — a product defined less by what it adds to a cycle and more by the stacking decisions it forces athletes to confront. Trenbolone Enanthate carries a pharmacological profile that makes certain co-administered compounds genuinely counterproductive, and understanding those pairings is as important as knowing the drug itself.

Compounds That Increase Prolactin Risk When Combined

Trenbolone Enanthate elevates prolactin through progestogenic receptor activity, and stacking it with other 19-nor compounds — most notably Nandrolone Decanoate or Nandrolone Phenylpropionate — compounds that same prolactin-mediated burden through additive progestogenic signalling. Published endocrinology literature consistently identifies dual-19-nor stacks as carrying a disproportionately elevated risk of prolactin-driven side effects compared to either compound alone. Athletes who add a second 19-nor agent alongside Trenabol should expect prolactin monitoring via serum assay to become non-negotiable, not optional. The combination is not therapeutically irrational in every context, but the risk-to-reward ratio deteriorates sharply compared to stacking Trenbolone Enanthate with non-progestogenic androgens such as Testosterone Enanthate or Masteron Propionate.

Hepatotoxic Combinations and Cardiovascular Loading

Oral 17-alpha-alkylated compounds — including Oxymetholone (Anadrol) and high-dose Stanozolol — present a distinct unfavorable interaction when combined with Trenbolone Enanthate. Trenbolone Enanthate itself does not aromatise, but it does exert significant pressure on lipid panels, suppressing HDL cholesterol in a dose-dependent manner documented across multiple pharmacokinetic assessments. Layering a hepatotoxic oral on top of that lipid burden accelerates cardiovascular risk in a non-linear fashion: the two insults act on overlapping pathways rather than independent ones. Trenabol's 150 mg/ml concentration — the lowest available in this product family — gives users the option to run a conservatively dosed Trenbolone Enanthate cycle while minimising the temptation to add aggressive oral compounds to compensate for perceived potency gaps.

Why Certain Aromatising Compounds Belong Elsewhere in the Stack

High-dose aromatising testosterone, when stacked with Trenbolone Enanthate without aromatase inhibitor control, creates a hormonal environment where managing oestrogen and prolactin simultaneously becomes operationally complex. The issue is not that testosterone and Trenbolone Enanthate cannot be combined — they routinely are — but that excessively high testosterone doses relative to Trenabol's milligram contribution shift the ancillary management burden beyond what a single aromatase inhibitor protocol can reliably address. A testosterone dose kept proportionate to the Trenbolone Enanthate dose, guided by bloodwork rather than volume targets, represents the evidence-aligned approach. Omega Meds supplies Trenabol in ten individually sealed ampoules precisely to support the kind of dose discipline this combination requires: each ampoule is a single discrete unit, not a reservoir inviting imprecise re-dosing.

Usage

Before opening the first ampoule, confirm your full stack via bloodwork: establish baseline prolactin, HDL cholesterol, and liver enzyme values — these are the markers most stressed by unfavorable Trenabol combinations.
Cross-check every planned co-administered compound against the two primary risk categories: other 19-nor androgens (additive prolactin burden) and oral 17-alpha-alkylated steroids (overlapping hepatic and lipid stress). Remove any flagged compounds before proceeding.
Snap open the single-dose ampoule immediately before injection — the sealed format ensures sterility is preserved until the moment of use; do not pre-draw and store.
Administer via intramuscular injection into a large muscle group (glute, vastus lateralis); rotate sites across the week's two injections to manage local tissue accumulation.
If testosterone is part of the stack, confirm via repeat bloodwork at week four that both oestrogen and prolactin remain within managed ranges before considering any dose escalation.
Store unused sealed ampoules at 15–25 °C, away from direct light and moisture; the ten-ampoule blister format keeps each unit factory-sealed until required.

Warnings

Contraindications: Trenabol is contraindicated in individuals with existing hepatic impairment, confirmed cardiovascular disease, hypersensitivity to Trenbolone or sesame/carrier oils, and those currently using other 19-nor compounds. Prostate conditions, elevated prolactin at baseline, and active psychiatric diagnoses are additional absolute contraindications.

Side Effects: Trenbolone Enanthate can cause androgenic effects including increased sebum production, accelerated scalp hair thinning in genetically predisposed individuals, and elevated aggression. Prolactin-mediated effects — including galactorrhoea and reduced libido — are a risk compounded dramatically by any co-administered 19-nor compound. Cardiovascular effects include suppressed HDL cholesterol, elevated LDL, and increased haematocrit; these are worsened by simultaneous use of hepatotoxic orals. Night sweats and reduced aerobic capacity are commonly reported and should prompt dose review.

Monitoring: Serum prolactin, full lipid panel, liver enzymes (ALT/AST), haematocrit, and blood pressure should be assessed at baseline, at week four, and at cycle conclusion. If a second compound is added mid-cycle, repeat prolactin and lipid testing within two weeks of introduction. Avoid adding new stack components without an intervening bloodwork checkpoint.

PCT: Post-cycle therapy should begin approximately 14–18 days after the final Trenabol ampoule, reflecting the enanthate ester's extended clearance window. A standard SERM protocol (Nolvadex or Clomid) for four to six weeks is the established approach. Prolactin normalisation should be confirmed via serum assay before PCT is considered complete, particularly if any progestogenic compound was co-administered during the cycle.

Frequently asked questions

Which compound categories should never be stacked with Trenbolone Enanthate due to additive progestogenic effects?: A second 19-nor androgen — specifically any form of Nandrolone — should not be combined with Trenbolone Enanthate. Both compounds activate the progesterone receptor, and their combined progestogenic load elevates prolactin to levels that a standard cabergoline protocol may struggle to control. Serum prolactin testing before and during any such stack is the minimum harm-reduction measure if the combination is attempted.
Why do 17-alpha-alkylated oral steroids represent an unfavorable addition to a Trenabol cycle?: Oral 17-alpha-alkylated compounds such as Oxymetholone introduce hepatic stress that overlaps with the lipid-panel suppression Trenbolone Enanthate already causes. Because both insults affect HDL and cardiovascular markers through partially shared pathways, the combined effect is non-additive in a dangerous direction — cardiovascular risk rises faster than either compound alone would predict. Liver enzyme panels and a full lipid profile should be checked before layering any oral on a Trenbolone Enanthate base.
What happens when high-dose aromatising testosterone is combined with Trenbolone Enanthate without proper ancillary management?: Running disproportionately high testosterone alongside Trenbolone Enanthate creates dual hormonal suppression of two separate axes — oestrogen and prolactin — simultaneously. A single aromatase inhibitor cannot address prolactin; cabergoline or bromocriptine handles prolactin, and an AI handles oestrogen. Managing both ancillary pathways effectively requires disciplined bloodwork, and the task becomes significantly harder when testosterone doses are high. Keeping testosterone in proportion to the Trenabol dose simplifies ancillary management considerably.
What is the advantage of Omega Meds Trenabol's 150mg/ml concentration compared to higher-concentration Trenbolone Enanthate products?: At 150 mg/ml, Trenabol is the lowest concentration in this product category, which gives users finer dose control per ampoule without drawing fractional volumes. Each 1 ml ampoule delivers exactly 150 mg — a figure that aligns with entry-level and harm-reduction dosing targets without requiring the sub-0.75ml draws that higher-concentration formulations demand. This makes precise weekly dose planning more straightforward for athletes who are simultaneously managing multiple ancillaries.
How does the single-dose ampoule format of Trenabol support safety when running a complex stack?: Each of Trenabol's ten ampoules is a sealed, single-use glass unit opened immediately before injection, which eliminates the repeated-needle-penetration contamination risk inherent to multi-use vials. When an athlete is already managing the increased monitoring burden of a multi-compound cycle, removing one potential sterility variable is a meaningful practical benefit. Unused ampoules remain factory-sealed until the moment of administration. (2) angle_used

Manufacturer

Authentication at Omega Meds is built directly into the product's physical presentation rather than handled as a post-sale afterthought. Each Trenabol ampoule carries a holographic security label with a unique alphanumeric code that can be cross-referenced against Omega Meds' verification database — a system designed so that any athlete, before injection, can confirm the ampoule in hand is from a released, documented batch. The verification architecture matters specifically for Trenabol because athletes running complex stacks around this compound need certainty that what they are dose-managing is what the label declares. A counterfeited or underdosed Trenbolone Enanthate product in a tightly managed stack does not just underperform — it invalidates the entire bloodwork-guided management framework built around it. Omega Meds publishes Certificate of Analysis data at the lot level, covering HPLC potency confirmation and LAL endotoxin results, making each batch independently auditable against the hologram code on the ampoule itself.

Product details

Brand	Omega Meds
Active ingredient	trenbolone enanthate
Also known as	Tren E, Trenbolone Enanthat, Trenabol, Omega Meds Tren E
Strength	150 mg
Form	Ampullen
Pack size	10 pieces
Item number	INJ-TENA-OME-150-016

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

High Concentration

Etho-Trenbolone 200mg/ml 10ml Vial by Beligas Pharmaceuticals

Etho-Trenbolone by Beligas Pharmaceuticals is a high-concentration Trenbolone Enanthate injectable, delivering 200 mg per millilitre across a 10 ml multi-dose vial, engineered to slot cleanly into structured modern cycling frameworks where predictable release and manageable injection volume are both priorities. Its extended-release enanthate ester makes it the long-acting trenbolone of choice when planners need to synchronise dosing windows with weekly cycle schedules rather than every-other-day logistics. Quality assurance at Beligas covers every production stage: HPLC potency verification confirms the 200 mg/ml specification, LAL endotoxin screening protects injectable sterility, and GMP-certified filling suites govern the final product release.

€54.00

Trenbolin-200 200mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Trenbolin-200 200mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Trenbolin-200 is a high-concentration Trenbolone Enanthate injectable, delivering 200mg of active steroid per millilitre across a pharmacokinetic profile defined by an extended half-life that sustains plasma levels for approximately 7–10 days post-injection. The enanthate ester governs the release curve: slower enzymatic cleavage compared to acetate esters produces a broad, stable concentration window rather than a sharp spike-and-trough pattern. Quality is assured through a multi-stage release protocol — HPLC potency verification, LAL endotoxin screening, and terminal sterility testing are applied to every batch before distribution.

€56.00

Brand Quality

ETrenaTrex 200mg/ml 10ml Vial by Concentrex Labs

ETrenaTrex is a Trenbolone Enanthate solution at 200 mg/ml in a 10 ml multi-dose vial, engineered specifically for athletes who structure their annual training calendar around defined blast and cruise phases rather than standalone cycles. The long-acting enanthate ester supports the extended administration windows that both the blast phase intensity and the cruise phase maintenance demand — delivering reliable tissue levels across each distinct period. Quality assurance is enforced at the batch level: every vial passes HPLC quantitative potency verification and LAL endotoxin testing before release from the Concentrex Labs facility.

€55.00

Pro Choice

Trenbolone 200 200mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma Trenbolone 200 is a long-acting injectable androgenic compound delivering 200 mg of Trenbolone Enanthate per millilitre, formulated specifically for experienced users who seek sustained hormonal optimization in age-related muscle loss and metabolic decline contexts. Where testosterone-only TRT reaches its limits — particularly in recomposition, nitrogen retention, and IGF-1 axis support — Trenbolone Enanthate offers a biochemically distinct intervention with a markedly higher androgen receptor binding affinity (Ki approximately 6–7× that of testosterone, per receptor-binding assay data). Quality is independently verifiable: each 10ml vial undergoes HPLC potency confirmation and LAL endotoxin testing at Dragon-Pharma's GMP-certified production facility before batch release.

€48.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00